Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring

A cell nucleic acid, detection body technology, applied in the direction of microbial determination/inspection, genomics, instruments, etc., can solve the problems of simplicity, inability to consider the impure nature of cfDNA, and inability to consider overlapping read partners, etc.

Pending Publication Date: 2020-06-12
RGT UNIV OF CALIFORNIA
View PDF7 Cites 12 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This probabilistic model may be too simplistic and may fail to account for the impure nature of cfDNA, resulting in a large number of false positives
In addition, these methods may fail to account for overlapping read mates in cfDNA sequencing data that can provide valuable information for detecting mutations in cfDNA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring
  • Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring
  • Detecting somatic single nucleotide variants from cell-free nucleic acid with application to minimal residual disease monitoring

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0056] The present disclosure provides probabilistic models for accurate and sensitive somatic single nucleotide variant (SNV) detection in cell-free deoxyribonucleic acid (cfDNA) samples and / or cell-free ribonucleic acid (cfRNA) samples, The sample comprises a sequence data set. cfDNA samples can be taken from plasma samples. The model can receive as input sequencing data from cfDNA and matched normal samples, such as from white blood cells in blood. In addition, since joint genotypes can be determined for each locus in a sequence dataset, germline mutations can be removed. In addition, since the overall tumor cfDNA fraction can be taken into account, accurate SNV detection can be performed from samples with low tumor fractions that might otherwise be unavailable.

[0057] As described herein, cfDNA from a subject (eg, a cancer patient) can comprise a mixture of DNA or RNA from cells of a diseased organ (eg, tumor cells) and DNA or RNA from normal cells. Therefore, the gen...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present disclosure provides a probabilistic model for accurate and sensitive somatic single nucleotide variant (SNV) detection in cell-free nucleic acid samples comprising a set of sequence data.A joint genotype may be determined for each locus in the set of sequence data, and germline mutations may be intrinsically removed. A set of filtrations can be applied to eliminate low quality somaticvariant calls. Further, a global tumor cell-free deoxyribonucleic acid (cfDNA) fraction and overlapping read mates can be considered, thereby enabling accurate SNV detection and variant allele frequency estimation from samples with low tumor cfDNA fraction. A sensitive early detection of minimal residual disease (MRD) is designed by using the probabilistic model and the machine learning model fordistinguishing true variants from sequencing errors.

Description

[0001] Cross References to Related Applications [0002] This application claims the benefit of U.S. Provisional Patent Application No. 62 / 559,366, filed September 15, 2017, which is expressly incorporated herein by reference in its entirety. [0003] Statement of Government Interests [0004] This invention was made with government support under HL108634 awarded by the National Institutes of Health. The government has certain rights in this invention. Background technique [0005] Somatic mutations can accumulate in cells throughout a subject's lifetime. While most such mutations may have little or no apparent effect, some may alter genes and / or key cellular functions and thus produce phenotypic changes. The products of somatic mutations can be cancers due to clonal expansion of cells and escape from both the in-built programs of normal somatic cell behavior and exogenous constraints on cell proliferation. Somatic mutations that trigger cancer progression may be referred ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6886G16B20/20G16B20/50
CPCC12Q1/6886G16B40/20G16B20/20
Inventor 向红·婕思敏·周李硕李文渊
Owner RGT UNIV OF CALIFORNIA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products